Mon, February 9, 2009
Sun, February 8, 2009
Fri, February 6, 2009
Thu, February 5, 2009
Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009

Inspire Announces Webcast of Presentation at BIO CEO Conference


//health-fitness.news-articles.net/content/2009/ .. bcast-of-presentation-at-bio-ceo-conference.html
Published in Health and Fitness on Tuesday, February 3rd 2009 at 4:29 GMT, Last Modified on 2009-02-03 04:29:38 by Market Wire   Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, will present at the BIO CEO & Investor Conference Tuesday, February 10, 2009 at 11:30 am ET in New York City.

The webcast of the presentation will be available on Inspire's web site at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire is currently developing products for dry eye, cystic fibrosis and glaucoma. Inspire employs a U.S. sales force for the promotion of AzaSite® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis and Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis. Elestat is a registered trademark owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit [ www.inspirepharm.com ].


Publication Contributing Sources